• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算轮状病毒疫苗对儿童死亡率的全球影响。

Estimating the global impact of rotavirus vaccines on child mortality.

机构信息

Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Int J Infect Dis. 2023 Dec;137:90-97. doi: 10.1016/j.ijid.2023.10.005. Epub 2023 Oct 18.

DOI:10.1016/j.ijid.2023.10.005
PMID:37863311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10689250/
Abstract

OBJECTIVES

We estimated the global impact of rotavirus vaccines on deaths among children under five years old by year.

METHODS

We used a proportionate outcomes model with a finely disaggregated age structure to estimate rotavirus deaths prevented by vaccination over the period 2006-2019 in 186 countries. We ran deterministic and probabilistic uncertainty analyses and compared our estimates to surveillance-based estimates in 20 countries.

RESULTS

We estimate that rotavirus vaccines prevented 139,000 under-five rotavirus deaths (95% uncertainty interval 98,000-201,000) in the period 2006-2019. In 2019 alone, rotavirus vaccines prevented 15% (95% uncertainty interval 11-21%) of under-five rotavirus deaths (0.5% of child mortality). Assuming global use of rotavirus vaccines and coverage equivalent to other co-administered vaccines could prevent 37% of under-five rotavirus deaths (1.2% of child mortality). Our estimates were sensitive to the choice of rotavirus mortality burden data and several vaccine impact modeling assumptions. The World Health Organization's recommendation to remove age restrictions in 2012 could have prevented up to 17,000 rotavirus deaths in the period 2013-2019. Our modeled estimates of rotavirus vaccine impact were broadly consistent with estimates from post-vaccination surveillance sites.

CONCLUSION

Rotavirus vaccines have made a valuable contribution to global public health. Enhanced rotavirus mortality prevention strategies are needed in countries with high mortality in under-5-year-old children.

摘要

目的

我们按年份估计了轮状病毒疫苗对五岁以下儿童死亡人数的全球影响。

方法

我们使用了一个具有精细分解年龄结构的比例结果模型,来估计 2006 年至 2019 年期间 186 个国家因疫苗接种而预防的轮状病毒死亡人数。我们进行了确定性和概率性不确定性分析,并将我们的估计与 20 个国家的监测为基础的估计进行了比较。

结果

我们估计,2006 年至 2019 年期间,轮状病毒疫苗预防了 139,000 例五岁以下轮状病毒死亡(95%置信区间 98,000-201,000)。仅在 2019 年,轮状病毒疫苗就预防了 15%(95%置信区间 11-21%)的五岁以下轮状病毒死亡(占儿童死亡率的 0.5%)。假设全球使用轮状病毒疫苗,并达到与其他共同接种疫苗的覆盖率,可预防 37%的五岁以下轮状病毒死亡(占儿童死亡率的 1.2%)。我们的估计对轮状病毒死亡率负担数据的选择和几种疫苗影响建模假设较为敏感。世界卫生组织在 2012 年建议取消年龄限制,这可能使 2013 年至 2019 年期间的轮状病毒死亡人数减少多达 17,000 人。我们对轮状病毒疫苗影响的模型估计与疫苗接种后监测点的估计基本一致。

结论

轮状病毒疫苗为全球公共卫生做出了宝贵贡献。在五岁以下儿童死亡率较高的国家,需要加强轮状病毒死亡率预防策略。

相似文献

1
Estimating the global impact of rotavirus vaccines on child mortality.估算轮状病毒疫苗对儿童死亡率的全球影响。
Int J Infect Dis. 2023 Dec;137:90-97. doi: 10.1016/j.ijid.2023.10.005. Epub 2023 Oct 18.
2
Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.取消轮状病毒疫苗接种的年龄限制:一项获益-风险建模分析。
PLoS Med. 2012;9(10):e1001330. doi: 10.1371/journal.pmed.1001330. Epub 2012 Oct 23.
3
Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.地理和经济异质性对尼日利亚轮状病毒腹泻负担的影响,以及疫苗接种的效果和成本效益。
PLoS One. 2020 May 29;15(5):e0232941. doi: 10.1371/journal.pone.0232941. eCollection 2020.
4
Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.全球、区域和国家 2000-2013 年轮状病毒<5 岁儿童死亡率估计。
Clin Infect Dis. 2016 May 1;62 Suppl 2(Suppl 2):S96-S105. doi: 10.1093/cid/civ1013.
5
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.人轮状病毒疫苗(HRV)和肺炎球菌多糖蛋白 D 结合疫苗(PHiD-CV)估计对免疫规划支持国家儿童发病率和死亡率的公共卫生影响。
Hum Vaccin Immunother. 2022 Dec 30;18(7):2135916. doi: 10.1080/21645515.2022.2135916. Epub 2022 Dec 12.
6
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.135 个低收入和中等收入国家的轮状病毒疫苗接种的死亡率降低益处和肠套叠风险:当前和替代方案的建模分析。
Lancet Glob Health. 2019 Nov;7(11):e1541-e1552. doi: 10.1016/S2214-109X(19)30412-7.
7
Vaccines for preventing rotavirus diarrhoea: vaccines in use.预防轮状病毒腹泻的疫苗:正在使用的疫苗
Cochrane Database Syst Rev. 2019 Oct 28;2019(10):CD008521. doi: 10.1002/14651858.CD008521.pub5.
8
Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study.评估 63 个不符合 Gavi 资助条件的中等收入国家开展轮状病毒疫苗接种的潜在经济和健康影响:建模研究。
Lancet Glob Health. 2021 Jul;9(7):e942-e956. doi: 10.1016/S2214-109X(21)00167-4. Epub 2021 Apr 20.
9
Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years.轮状病毒疫苗接种与 5 岁以下儿童轮状病毒腹泻的全球负担。
JAMA Pediatr. 2018 Oct 1;172(10):958-965. doi: 10.1001/jamapediatrics.2018.1960.
10
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.2008 年全球轮状病毒相关死亡率估计:在普遍轮状病毒疫苗接种计划推出之前,5 岁以下儿童:系统评价和荟萃分析。
Lancet Infect Dis. 2012 Feb;12(2):136-41. doi: 10.1016/S1473-3099(11)70253-5. Epub 2011 Oct 24.

引用本文的文献

1
Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillance.阿富汗轮状病毒疫苗接种的成本效益及利弊分析:一项基于上市后监测的模型分析
BMC Health Serv Res. 2025 Jul 4;25(1):926. doi: 10.1186/s12913-025-12885-5.
2
Vaccines, equity and sovereignty: Science for the world from Colombia.疫苗、公平与主权:来自哥伦比亚的全球科学
Biomedica. 2025 May 30;45(2):169-172. doi: 10.7705/biomedica.8030.
3
A report for the fifth International Workshop on Rotavirus and Norovirus in China.

本文引用的文献

1
Systematic review of the effect of additional doses of oral rotavirus vaccine on immunogenicity and reduction in diarrhoeal disease among young children.口服轮状病毒疫苗额外剂量对幼儿免疫原性及腹泻病减少效果的系统评价。
EClinicalMedicine. 2022 Oct 6;54:101687. doi: 10.1016/j.eclinm.2022.101687. eCollection 2022 Dec.
2
Predicting the long-term impact of rotavirus vaccination in 112 countries from 2006 to 2034: A transmission modeling analysis.预测 2006 年至 2034 年 112 个国家轮状病毒疫苗接种的长期影响:传播建模分析。
Vaccine. 2022 Nov 2;40(46):6631-6639. doi: 10.1016/j.vaccine.2022.09.072. Epub 2022 Oct 6.
3
一份关于中国第五届轮状病毒与诺如病毒国际研讨会的报告。
Hum Vaccin Immunother. 2025 Dec;21(1):2512647. doi: 10.1080/21645515.2025.2512647. Epub 2025 Jun 9.
4
Rotavirus Infections: Pathophysiology, Symptoms, and Vaccination.轮状病毒感染:病理生理学、症状及疫苗接种
Pathogens. 2025 May 14;14(5):480. doi: 10.3390/pathogens14050480.
5
Analysis of Under-Five Mortality Rate in Saudi Arabia: 1973 to 2022.沙特阿拉伯五岁以下儿童死亡率分析:1973年至2022年
Cureus. 2025 Jan 27;17(1):e78048. doi: 10.7759/cureus.78048. eCollection 2025 Jan.
6
Geographic disparities impacting oral vaccine performance: Observations and future directions.影响口服疫苗效果的地域差异:观察结果与未来方向。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae124.
7
Effectiveness and impact of monovalent rotavirus vaccination in Afghanistan: a test-negative case-control analysis.单价轮状病毒疫苗在阿富汗的有效性和影响:病例对照测试阴性分析。
Lancet Glob Health. 2024 Sep;12(9):e1517-e1525. doi: 10.1016/S2214-109X(24)00237-7.
8
Circulating rotavirus strains in children with acute gastroenteritis in Iran, 1986 to 2023 and their genetic/antigenic divergence compared to approved vaccines strains (Rotarix, RotaTeq, ROTAVAC, ROTASIIL) before mass vaccination: Clues for vaccination policy makers.伊朗 1986 年至 2023 年急性胃肠炎患儿中循环轮状病毒株及其与大规模接种前批准疫苗株(Rotarix、RotaTeq、ROTAVAC、ROTASIIL)的遗传/抗原差异:为疫苗政策制定者提供线索。
Virus Res. 2024 Aug;346:199411. doi: 10.1016/j.virusres.2024.199411. Epub 2024 Jun 3.
9
Estimated global and regional causes of deaths from diarrhoea in children younger than 5 years during 2000-21: a systematic review and Bayesian multinomial analysis.2000-21 年期间,全球和各区域导致 5 岁以下儿童腹泻死亡的原因估计:系统评价和贝叶斯多项分析。
Lancet Glob Health. 2024 Jun;12(6):e919-e928. doi: 10.1016/S2214-109X(24)00078-0. Epub 2024 Apr 20.
Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals.
2000-19 年全球、区域和国家 5 岁以下儿童死亡原因:一项更新的系统分析及其对可持续发展目标的影响。
Lancet Child Adolesc Health. 2022 Feb;6(2):106-115. doi: 10.1016/S2352-4642(21)00311-4. Epub 2021 Nov 17.
4
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.在 COVID-19 大流行之前的世界中,疫苗接种拯救了 112 个国家的 10 种病原体感染的 10 亿人生命。
Elife. 2021 Jul 13;10:e67635. doi: 10.7554/eLife.67635.
5
Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis.2006-2019 年轮状病毒疫苗的真实世界效果:文献回顾和荟萃分析。
Lancet Glob Health. 2020 Sep;8(9):e1195-e1202. doi: 10.1016/S2214-109X(20)30262-X.
6
Impact of a twelve-year rotavirus vaccine program on acute diarrhea mortality and hospitalization in Brazil: 2006-2018.巴西十二年轮状病毒疫苗计划对急性腹泻死亡率和住院率的影响:2006-2018 年。
Expert Rev Vaccines. 2020 Jun;19(6):585-593. doi: 10.1080/14760584.2020.1775081. Epub 2020 Jun 16.
7
Global Impact of Rotavirus Vaccination on Diarrhea Hospitalizations and Deaths Among Children <5 Years Old: 2006-2019.轮状病毒疫苗接种对 5 岁以下儿童腹泻住院和死亡的全球影响:2006-2019 年。
J Infect Dis. 2020 Oct 13;222(10):1731-1739. doi: 10.1093/infdis/jiaa081.
8
Drivers of the reduction in childhood diarrhea mortality 1980-2015 and interventions to eliminate preventable diarrhea deaths by 2030.1980-2015 年儿童腹泻死亡率下降的驱动因素以及到 2030 年消除可预防腹泻死亡的干预措施。
J Glob Health. 2019 Dec;9(2):020801. doi: 10.7189/jogh.09.020801.
9
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.135 个低收入和中等收入国家的轮状病毒疫苗接种的死亡率降低益处和肠套叠风险:当前和替代方案的建模分析。
Lancet Glob Health. 2019 Nov;7(11):e1541-e1552. doi: 10.1016/S2214-109X(19)30412-7.
10
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.根据随访时间评估口服活轮状病毒疫苗的疗效:一项随机对照试验的荟萃回归分析。
Lancet Infect Dis. 2019 Jul;19(7):717-727. doi: 10.1016/S1473-3099(19)30126-4. Epub 2019 Jun 6.